Research presented in the New England Journal of Medicine unveiled an obesity drug that may help adolescents lose weight.
Known as semaglutide, researchers studied its effect by recruiting 201 participants.
“A total of 201 participants underwent randomization, and 180 (90%) completed treatment. All but one of the participants had obesity,” according to the study’s authors.
What the study found: “Among adolescents with obesity, once-weekly treatment with a 2.4-mg dose of semaglutide plus lifestyle intervention resulted in a greater reduction in BMI than lifestyle intervention alone.”
The findings were published November 2, 2022.
